[144] Perimeter Solutions, Inc. SEC Filing

Rhea-AI Filing Summary

Perimeter Solutions, Inc. (PRM) filing a Form 144 notifies a proposed sale of 40,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $881,976. The shares represent a small fraction of the company's outstanding common stock of 146,452,138 shares. The filing indicates the shares were acquired and paid for on 09/05/2025 through exercise of options under a registered plan and paid in cash.

The filer certifies there is no undisclosed material adverse information about the issuer. No other sales by the filer in the prior three months are reported. This notice documents an insider liquidity event but provides no financial results, operational updates, or forward-looking disclosures.

Insights

Securities Analyst

TL;DR: Small insider sale via option exercise; unlikely to be material to PRM's market valuation.

The Form 144 reports a proposed sale of 40,000 shares valued at $881,976, acquired and paid the same day via option exercise. Relative to the reported 146.45 million shares outstanding, the position size is immaterial (~0.03%). The filing meets disclosure requirements for an insider sale but does not convey any new operational or financial information about Perimeter Solutions. For investors, this is routine insider liquidity rather than a signal of company performance.

Corporate Governance Expert

TL;DR: Routine compliance filing documenting an insider exercising options and planning a sale; governance implications are minimal.

The notice includes the required attestation that no undisclosed material adverse information is known. The acquisition method (exercise under a registered plan) and immediate proposed sale are common and permissible. Absent additional contextual disclosures (e.g., unusually timed clustered insider sales), this transaction does not raise governance red flags. Documentation appears complete for a Form 144 submission.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	40000	881976.00	146452138	09/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/05/2025	Exercise of options under a registered plan	Issuer			40000	09/05/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Perimeter Solutions (PRM) Form 144 report?

It reports a proposed sale of 40,000 common shares valued at $881,976 to be sold through Morgan Stanley Smith Barney on 09/05/2025.

How were the PRM shares acquired that are being sold?

The shares were acquired on 09/05/2025 by exercising options under a registered plan and paid in cash on the same date.

How large is the proposed sale relative to PRM's outstanding stock?

The filing shows 146,452,138 shares outstanding, so the 40,000-share sale is approximately 0.03% of outstanding shares.

Does the Form 144 disclose any other recent sales by the filer?

No. The filing states "Nothing to Report" for securities sold during the past three months by the filer.

Does the filer assert any undisclosed material information about PRM?

By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.